← Back to Patent Explorer
US3894002A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted naphthylalkylene lactamimides

Assignee: Richardson Vicks Inc
•
Filing: 1973-08-09
•
Granted: 1975-07-08
•
Expires: 1993-08-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds possessing hypoglycemic, anticoagulant and diuretic activity are represented by compounds of the following formula WHEREIN EACH R is hydrogen, halogen such as chlorine, fluorine or bromine, trifluoromethyl, a straight or branched alkyl chain of from 1 to 12 carbon atoms, alkoxy of from 1 to 3 carbon atoms, or nitro, and each R may be the same or different; Y is a straight or branched alkylene chain of from 1 to 6 carbon atoms and is optionally substituted with phenyl or substituted phenyl wherein the substituents on the substituted phenyl are selected from halogen such as fluorine, chlorine, bromine or iodine or lower alkyl of from 1 to 3 carbon atoms; R2 is hydrogen or lower alkyl of from 1 to 4 carbon atoms; R3 is hydrogen, lower alkyl of from 1 to 4 carbon atoms or halogen such as chlorine, fluorine, bromine or iodine; and n is an integer of from 3 to 11.

Inventors

  • 👤 Robert D Mackenzie
  • 👤 Thomas R Blohm
  • 👤 Edward M Roberts

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 05:37
CPC Classifications
C; C07; C07C; C07C49/00; C07C49/76; C07C49/80; C07C49/813

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 10 words
A COMPOUND SELECTED FROM A. A COMPOUND OF THE FORMULA
Claim 2
Dependent Claim 10 words
A COMPOUND SELECTED FROM A. A COMPOUND OF THE FORMULA
Claim 3
Dependent Claim 8 words
A compound of claim 1 wherein Y is
Claim 4
Dependent Claim 9 words
A compound of claim 3 wherein X is methyl.
Claim 5
Dependent Claim 10 words
A compound of claim 3 wherein each R is hydrogen.
Claim 6
Dependent Claim 17 words
A compound of claim 4 which is hexahydro-2-(1-(1-naphthyl)ehtylimino) azepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 7
Dependent Claim 16 words
A compound of claim 4 which is 2-(1-(2-naphthyl)ethylimino)hexahydroazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 8
Dependent Claim 16 words
A compound of claim 4 which is 2-(1-(1-naphthyl)ethylimino)octahydroazocine or a pharmaceutically acceptable acid addition salt thereof.
Claim 9
Dependent Claim 17 words
A compound of claim 3 which is 2-(1-(4-chloro-1-naphthyl)ethylimino) hexahydroazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 10
Dependent Claim 17 words
A compound of claim 3 which is 2-(1-(5,8-dimethyl-1-naphthyl)ethylimino) hexahydroazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 11
Dependent Claim 17 words
A compound of claim 2 which is 2-(2-methyl-1-(1-naphthyl)propylimino) hexahydroazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 12
Dependent Claim 8 words
A compound of claim 1 wherein Y is
Claim 13
Dependent Claim 17 words
A compound of claim 11 which is hexahydro-2-((o-methyl-Alpha -(1-naphthyl)benzyl)imino)azepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 14
Dependent Claim 18 words
A compound of claim 11 which is 2-(( Alpha -(4-fluoro-1-naphthyl)benzyl)imino)piperidine or a pharmaceutically acceptable acid addition salt thereof.

References Cited (Backward Citations)

US3378438A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-07-07 1979-01-06 1979-07-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-07-07 1983-01-06 1983-07-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-07-07 1987-01-06 1987-07-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag